SWP
AXDX

Stratos Wealth Partners’s Accelerate Diagnostics AXDX Stock Holding History

Stratos Wealth Partners’s Portfolio AXDX Stock Details AXDX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-10,628
Closed -$12.8K – 1375
2024
Q4 		$12.8K Buy
+10,628
New +$17.6K ﹤0.01% 1444

Other funds holding AXDX

AC
Armistice Capital New York $8.17B AUM 68.82% 1-Year Est. Return
GAM
Griffin Asset Management New York $949M AUM 24.98% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BC
Birchview Capital Burlington, Vermont $214M AUM 185.33% 1-Year Est. Return
Lido Advisors
Lido Advisors Los Angeles, California $36.8B AUM 26.6% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
CS
Cannell & Spears New York $5.62B AUM 41.25% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
TWA
TCI Wealth Advisors Tucson, Arizona $2.31B AUM 26.52% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $1.28T AUM 58.89% 1-Year Est. Return

Stratos Wealth Partners's AXDX Position: Q1 2025 in Review

Stratos Wealth Partners sold out of Accelerate Diagnostics (AXDX) in Q1 2025, closing a stake of 10,628 shares — an estimated $12.8K sold.

Stratos Wealth Partners first reported a position in AXDX in Q4 2024 and held it in 1 quarter. The position peaked at $12.8K in Q4 2024. 43 funds tracked by Wall St. Rank hold AXDX as of Q1 2025.

  • Stratos Wealth Partners reported no remaining Accelerate Diagnostics position as of Q1 2025 after selling out during the quarter.
  • Stratos Wealth Partners sold 10,628 Accelerate Diagnostics shares in Q1 2025, an estimated $12.8K.
  • Stratos Wealth Partners first reported a position in Accelerate Diagnostics in Q4 2024 and held it in 1 quarter.
  • Stratos Wealth Partners's Accelerate Diagnostics position peaked at $12.8K in Q4 2024.
  • 43 funds tracked by Wall St. Rank held Accelerate Diagnostics as of Q1 2025.

Based on Stratos Wealth Partners's 13F filing for Q1 2025, filed 30 Apr 2025.